Week of April 11, 2023 | Vol. 12, Issue 14


In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates

Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health

Contact Information

Xan Smith

Managing Director

Business Development


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory


Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.


Events Hosted or Attended by Bourne Partners

gold-hero-850-bg image
CPHI-North-America-logo-web image
en_bnr_home_global01 image

NACDS Annual Meeting 2023

April 22-25, 2023 - West Palm Beach, FL

CPHI North America

April 25-27, 2023 - Philadelphia, PA


April 25-27, 2023 - New York City, NY

BIO International 2023

June 5-8, 2023 - Boston, MA

DIA Global 2023

June 25-29, 2023 - Boson, MA


Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

6 transactions totaling $97 million

Supplies, Equipment & Services

20 transactions totaling $1.7 billion

Healthcare Facilities & Distributors

7 transactions totaling $38 million

Healthcare IT & Managed Care

7 transactions

Private Placements

Pharma & Biotech

31 transactions totaling $335 million

Supplies, Equipment & Services

11 transactions totaling $87 million

Healthcare Facilities & Distributors

2 transactions totaling $21 million

Healthcare IT & Managed Care

8 transactions totaling $238 million

Public Offerings

Pharma & Biotech

21 transactions totaling $427 million

Supplies, Equipment & Services

6 transactions totaling $122 million

Healthcare Facilities & Distributors

2 transactions totaling $6 million

Healthcare IT & Managed Care

1 transaction

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and portfolio

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Sartorius to acquire Polyplus

Sartorius - Mar 31, 2023

Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer

PR Newswire - Apr 3, 2023

BioNTech pays $170M to add would-be Enhertu rival to pipeline, expanding into ADCs in the process

Fierce Biotech - Apr 3, 2023

Goodwin Biotechnology Inc. (GBI) Announces First Commercial Contract Signing

PR Newswire - Apr 4, 2023

From 'transformative' to 'tremendous fear': Takes on ChatGPT in healthcare at ViVE 2023

Fierce Healthcare - Apr 4, 2023

Bridgewest Group launches NovaCina, new sterile injectable CDMO

PR Newswire - Apr 4, 2023

Concept Life Sciences snapped up by investment group

Fierce Biotech - Apr 4, 2023

Solvay Announces Strategic Collaboration With Ginkgo Bioworks And Expands Its R&I Footprint In The United States

PR Newswire - Apr 4, 2023

Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352

Societal CDMO - Apr 5, 2023

Ginkgo Bioworks Strengthens End-to-End R&D Capabilities in Gene Therapy through Acquisition of StrideBio's AAV Capsid Discovery and Engineering Platform Assets

PR Newswire - Apr 5, 2023

Bora Pharmaceuticals, Celltrion Partner to Expand OSD Capabilities in the APAC Market

Contract Pharma - Apr 6, 2023


Welcome Jennifer Buchanan!

Welcome aboard Jennifer Buchanan! We’re thrilled that you’re bringing your unique perspective and background to our team!

Jennifer has joined Bourne Partners to aid and support our Business Development efforts. She's excited to engage those in the industry to advise and support as they consider their strategic goals.

Connect with Jennifer on LinkedIn below:




A Resource for Accessing Rare Disease Therapies Globally

Rare disease patients often lack access to innovative treatment options because the required therapy is not commercially available in their country. Access Programs can help to bridge this gap, offering patients an alternative pathway to the medicine they need. Learn more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.